美国人类免疫缺陷病毒感染个体中心肌梗死类型的特征分析
该纵向研究纳入美国6个中心1996年1月1日至2014年3月1日期间接受临床诊疗的HIV感染者,由两名医师专家裁定明确或很可能的心肌梗死并分型。571例患者中,2型心肌梗死288例(50.4%),1型283例(49.6%);2型最常见病因为脓毒症或菌血症(100例,34.7%)及近期使用可卡因或其他违禁药物(39例,13.5%)。
要点
- HIV感染者中约半数心肌梗死为2型,由脓毒症或菌血症、近期使用可卡因或其他违禁药物等异质性临床情况所致。
- 2型心肌梗死患者中年龄小于40岁者比例高于1型或接受心脏干预者(47/288 vs 32/362)。
- 2型心肌梗死患者当前CD4细胞计数中位数、总胆固醇水平及Framingham风险评分均低于1型或接受心脏干预者。
核心结论
- HIV感染者中约半数心肌梗死为2型,由包括脓毒症或菌血症及近期使用可卡因或其他违禁药物在内的异质性临床情况所致。
- 1型与2型心肌梗死患者的人口学特征和心血管危险因素存在差异,作者认为需在HIV感染者中特别考虑心肌梗死分型,以进一步理解心肌梗死结局并指导预防和治疗。
研究设计与样本
- 纵向研究,识别1996年1月1日至2014年3月1日在美国6个中心接受临床诊疗的HIV感染者中的潜在心肌梗死。
- 利用集中数据仓库中记录的确诊和心脏生物标志物识别事件,各中心汇编去标识化资料包,包括医师记录、心电图、操作和临床实验室检查。
- 由两名医师专家裁定每个事件,将每例明确或很可能的心肌梗死分为1型或2型,并确定2型心肌梗死的病因。
主要发现
- 571例明确或很可能心肌梗死患者(中位年龄49岁[四分位距43-55岁];430例男性、141例女性)中,2型心肌梗死288例(50.4%),1型283例(49.6%)。
- 1型心肌梗死分析中另纳入79例接受冠状动脉旁路移植术等心脏干预的患者,合计362例。
- 2型心肌梗死最常见病因为脓毒症或菌血症(100例[34.7%])和近期使用可卡因或其他违禁药物(39例[13.5%])。
- 2型心肌梗死患者中年龄小于40岁者比例为47/288(16.3%),1型或接受心脏干预者为32/362(8.8%)。
- 2型心肌梗死患者当前CD4细胞计数中位数为230 vs 383 cells/µL,平均(SD)总胆固醇水平为167(63)vs 190(54)mg/dL,平均(SD)Framingham风险评分为8%(7%)vs 10%(8%),均低于1型或接受心脏干预者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The Second Universal Definition of Myocardial Infarction (MI) divides MIs into different types. Type 1 MIs result spontaneously from instability of atherosclerotic plaque, whereas type 2 MIs occur in the setting of a mismatch between oxygen demand and supply, as with severe hypotension. Type 2 MIs are uncommon in the general population, but their frequency in human immunodeficiency virus (HIV)-infected individuals is unknown. OBJECTIVES: To characterize MIs, including type; identify causes of type 2 MIs; and compare demographic and clinical characteristics among HIV-infected individuals with type 1 vs type 2 MIs. DESIGN, SETTING, AND PARTICIPANTS: This longitudinal study identified potential MIs among patients with HIV receiving clinical care at 6 US sites from January 1, 1996, to March 1, 2014, using diagnoses and cardiac biomarkers recorded in the centralized data repository. Sites assembled deidentified packets, including physician notes and electrocardiograms, procedures, and clinical laboratory tests. Two physician experts adjudicated each event, categorizing each definite or probable MI as type 1 or type 2 and identifying the causes of type 2 MI. MAIN OUTCOMES AND MEASURES: The number and proportion of type 1 vs type 2 MIs, demographic and clinical characteristics among those with type 1 vs type 2 MIs, and the causes of type 2 MIs. RESULTS: Among 571 patients (median age, 49 years [interquartile range, 43-55 years]; 430 men and 141 women) with definite or probable MIs, 288 MIs (50.4%) were type 2 and 283 (49.6%) were type 1. In analyses of type 1 MIs, 79 patients who underwent cardiac interventions, such as coronary artery bypass graft surgery, were also included, totaling 362 patients. Sepsis or bacteremia (100 [34.7%]) and recent use of cocaine or other illicit drugs (39 [13.5%]) were the most common causes of type 2 MIs. A higher proportion of patients with type 2 MIs were younger than 40 years (47 of 288 [16.3%] vs 32 of 362 [8.8%]) and had lower current CD4 cell counts (median, 230 vs 383 cells/µL), lipid levels (mean [SD] total cholesterol level, 167 [63] vs 190 [54] mg/dL, and mean (SD) Framingham risk scores (8% [7%] vs 10% [8%]) than those with type 1 MIs or who underwent cardiac interventions. CONCLUSIONS AND RELEVANCE: Approximately half of all MIs among HIV-infected individuals were type 2 MIs caused by heterogeneous clinical conditions, including sepsis or bacteremia and recent use of cocaine or other illicit drugs. Demographic characteristics and cardiovascular risk factors among those with type 1 and type 2 MIs differed, suggesting the need to specifically consider type among HIV-infected individuals to further understand MI outcomes and to guide prevention and treatment.
引用
- Crane HM, Paramsothy P, Drozd DR, et al. Types of Myocardial Infarction Among Human Immunodeficiency Virus-Infected Individuals in the United States. JAMA Cardiol. 2017. PMID: 28052152. doi:10.1001/jamacardio.2016.5139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。